Uptake and predictors of direct-acting antiviral treatment for hepatitis C among people receiving opioid agonist therapy in Sweden and Norway: a drug utilization study from 2014 to 2017-Reference-Cited by-同舟云学术

Uptake and predictors of direct-acting antiviral treatment for hepatitis C among people receiving opioid agonist therapy in Sweden and Norway: a drug utilization study from 2014 to 2017

Published:2020-06-30 Issue:1 Volume:15 Page:
ISSN:1747-597X
Container-title:Substance Abuse Treatment, Prevention, and Policy
language:en
Short-container-title:Subst Abuse Treat Prev Policy

Author:

Aas Christer F.^ORCID,Vold Jørn Henrik,Skurtveit Svetlana,Odsbu Ingvild,Chalabianloo Fatemeh,Lim Aaron G.,Johansson Kjell Arne,Fadnes Lars Thore

Funder

Norges Forskningsråd

Helse Vest

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health,Health Policy

Link

http://link.springer.com/content/pdf/10.1186/s13011-020-00286-2.pdf

Reference46 articles.

1. Pecoraro V, Banzi R, Cariani E, Chester J, Villa E, D'Amico R, Bertele V, Trenti T. New direct-acting antivirals for the treatment of patients with Hepatitis C virus infection: a systematic review of randomized controlled trials. J Clin Exp Hepatol. 2019;9(4):522–38.

2. Pearlman BL, Traub N. Sustained virologic response to antiviral therapy for chronic hepatitis C virus infection: a cure and so much more. Clin Infect Dis. 2011;52(7):889–900.

3. Manns MP, Buti M, Gane E, Pawlotsky JM, Razavi H, Terrault N, Younossi Z. Hepatitis C virus infection. Nat Rev Dis Primers. 2017;3:17006.

4. Aspinall EJ, Corson S, Doyle JS, Grebely J, Hutchinson SJ, Dore GJ, Goldberg DJ, Hellard ME. Treatment of hepatitis C virus infection among people who are actively injecting drugs: a systematic review and meta-analysis. Clin Infect Dis. 2013;57(Suppl 2):S80–9.

5. Nelson PK, Mathers BM, Cowie B, Hagan H, Des Jarlais D, Horyniak D, Degenhardt L. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet (London, England). 2011;378(9791):571–83.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real‐world hepatitis C prevalence and treatment uptake at opioid agonist therapy clinics in Ontario, Canada;Journal of Viral Hepatitis;2024-02-22

2. Effect of integrated hepatitis C virus treatment on psychological distress in people with substance use disorders;Scientific Reports;2024-01-08

3. No effect of integrated hepatitis C virus treatment on psychological distress in people with substance use disorders: results from a randomized controlled trial;2023-09-13

4. Real-world hepatitis C treatment outcomes and reinfections among people who inject drugs at a needle and syringe program in Stockholm, Sweden;Harm Reduction Journal;2023-06-12

5. Hepatitis C treatment uptake among people who inject drugs in Oslo, Norway: A registry-based study;International Journal of Drug Policy;2023-06